KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Receivables - Other (2018 - 2023)

Historic Receivables - Other for Biogen (BIIB) over the last 9 years, with Q1 2023 value amounting to $6.3 million.

  • Biogen's Receivables - Other fell 9843.56% to $6.3 million in Q1 2023 from the same period last year, while for Mar 2023 it was $6.3 million, marking a year-over-year decrease of 9843.56%. This contributed to the annual value of $2.0 million for FY2022, which is 9929.92% down from last year.
  • According to the latest figures from Q1 2023, Biogen's Receivables - Other is $6.3 million, which was down 9843.56% from $2.0 million recorded in Q4 2022.
  • Biogen's 5-year Receivables - Other high stood at $402.7 million for Q1 2022, and its period low was $2.0 million during Q4 2022.
  • Over the past 5 years, Biogen's median Receivables - Other value was $85.0 million (recorded in 2019), while the average stood at $119.6 million.
  • As far as peak fluctuations go, Biogen's Receivables - Other surged by 8888.15% in 2021, and later plummeted by 9929.92% in 2022.
  • Quarter analysis of 5 years shows Biogen's Receivables - Other stood at $85.0 million in 2019, then surged by 77.76% to $151.1 million in 2020, then soared by 88.88% to $285.4 million in 2021, then tumbled by 99.3% to $2.0 million in 2022, then soared by 215.0% to $6.3 million in 2023.
  • Its Receivables - Other was $6.3 million in Q1 2023, compared to $2.0 million in Q4 2022 and $110.6 million in Q3 2022.